Friday, July 04, 2025 11:58:37 AM
Doc Logic - The agency has a HUGE credibility problem, least of which goes unnoticed by 🙊🙈🙉 investors still assuming older paradigms are in play. The enormous pubic pressure to remove COVID-19 vaccines from the childhood vaccine schedule, albeit not entirely from the market, moved the three agency directors to remove recommending the vaccine for healthy children and pregnant women. This action helped shape my opinion about the new leadership's integrity. Despite the availability of unrelenting peer reviewed papers literally coming out on the daily, and massive data sets used, as confirmatory of no benefit, but mostly, asymptomatic and or symptomatic harm, demonstrates that these men are to a degree compromised. It doesn't necessarily mean they're corrupt, but rather, they may have decided to pick and choose their battles selectively, to maintain their positions long enough, to see public sentiment deride the power of special interests.
A recently leaked communication dump btw BP interests and congressional representatives point to a $2 million allocation to pay for an elaborate psychological campaign through various media platforms to get RFK Jr. ousted by September 2025.
IMHO, these directors are FULLY aware and meaning to leapfrog passed the degraceful approval record this two year investigation revealed:
https://childrenshealthdefense.org/defender/fda-approved-hundreds-drugs-no-evidence-they-work/
A recently leaked communication dump btw BP interests and congressional representatives point to a $2 million allocation to pay for an elaborate psychological campaign through various media platforms to get RFK Jr. ousted by September 2025.
IMHO, these directors are FULLY aware and meaning to leapfrog passed the degraceful approval record this two year investigation revealed:
https://childrenshealthdefense.org/defender/fda-approved-hundreds-drugs-no-evidence-they-work/
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
